Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluLaval Quadrivalent in Adults and Elderly
NCT01440387Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2011
- Primary completion
- Oct 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza virus vaccine, quadrivalent, split virion in influenza, sponsored by GSK. Started Sep 2011; status: completed.
02
Drugs
influenza virus vaccine, quadrivalent, split virion
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01440387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01440387.